Cite
Kidney and heart failure outcomes associated with SGLT2 inhibitor use.
MLA
van der Aart-van der Beek, Annemarie B., et al. “Kidney and Heart Failure Outcomes Associated with SGLT2 Inhibitor Use.” Nature Reviews Nephrology, vol. 18, no. 5, May 2022, pp. 294–306. EBSCOhost, https://doi.org/10.1038/s41581-022-00535-6.
APA
van der Aart-van der Beek, A. B., de Boer, R. A., & Heerspink, H. J. L. (2022). Kidney and heart failure outcomes associated with SGLT2 inhibitor use. Nature Reviews Nephrology, 18(5), 294–306. https://doi.org/10.1038/s41581-022-00535-6
Chicago
van der Aart-van der Beek, Annemarie B., Rudolf A. de Boer, and Hiddo J. L. Heerspink. 2022. “Kidney and Heart Failure Outcomes Associated with SGLT2 Inhibitor Use.” Nature Reviews Nephrology 18 (5): 294–306. doi:10.1038/s41581-022-00535-6.